![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: FAM96B |
Gene summary for FAM96B |
![]() |
Gene information | Species | Human | Gene symbol | FAM96B | Gene ID | 51647 |
Gene name | cytosolic iron-sulfur assembly component 2B | |
Gene Alias | CGI-128 | |
Cytomap | 16q22.1 | |
Gene Type | protein-coding | GO ID | GO:0006790 | UniProtAcc | Q9Y3D0 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
51647 | FAM96B | P5_S10_cSCC | Human | Skin | cSCC | 1.70e-22 | -4.86e-01 | -0.299 |
51647 | FAM96B | P1_cSCC | Human | Skin | cSCC | 8.64e-26 | 1.02e+00 | 0.0292 |
51647 | FAM96B | P2_cSCC | Human | Skin | cSCC | 2.04e-17 | 6.12e-01 | -0.024 |
51647 | FAM96B | P4_cSCC | Human | Skin | cSCC | 2.43e-28 | 9.91e-01 | -0.00290000000000005 |
51647 | FAM96B | P10_cSCC | Human | Skin | cSCC | 1.84e-46 | 1.31e+00 | 0.1017 |
51647 | FAM96B | cSCC_p4 | Human | Skin | cSCC | 2.04e-05 | 9.41e-03 | -0.2022 |
51647 | FAM96B | cSCC_p6 | Human | Skin | cSCC | 8.81e-04 | -1.16e-01 | -0.1989 |
51647 | FAM96B | cSCC_p8 | Human | Skin | cSCC | 2.14e-10 | 2.62e-02 | -0.1971 |
51647 | FAM96B | cSCC_p9 | Human | Skin | cSCC | 3.33e-07 | -1.13e-02 | -0.1991 |
51647 | FAM96B | male-WTA | Human | Thyroid | PTC | 5.45e-11 | -4.69e-01 | 0.1037 |
51647 | FAM96B | female-WTA | Human | Thyroid | PTC | 8.06e-03 | -4.69e-01 | 0.0726 |
51647 | FAM96B | nodule-WTA | Human | Thyroid | goiters | 2.02e-08 | -4.69e-01 | 0.0534 |
51647 | FAM96B | PTC01 | Human | Thyroid | PTC | 1.52e-07 | 3.39e-01 | 0.1899 |
51647 | FAM96B | PTC04 | Human | Thyroid | PTC | 3.69e-03 | 5.07e-01 | 0.1927 |
51647 | FAM96B | PTC05 | Human | Thyroid | PTC | 2.91e-16 | 1.24e+00 | 0.2065 |
51647 | FAM96B | PTC06 | Human | Thyroid | PTC | 2.73e-24 | 9.63e-01 | 0.2057 |
51647 | FAM96B | PTC07 | Human | Thyroid | PTC | 1.08e-51 | 1.07e+00 | 0.2044 |
51647 | FAM96B | ATC09 | Human | Thyroid | ATC | 3.34e-06 | 2.49e-01 | 0.2871 |
51647 | FAM96B | ATC11 | Human | Thyroid | ATC | 3.77e-07 | 6.85e-01 | 0.3386 |
51647 | FAM96B | ATC12 | Human | Thyroid | ATC | 6.26e-03 | 6.09e-02 | 0.34 |
Page: 1 2 3 4 5 6 7 8 9 10 11 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FAM96B | SNV | Missense_Mutation | c.484C>T | p.Arg162Cys | p.R162C | Q9Y3D0 | protein_coding | tolerated_low_confidence(0.1) | benign(0.01) | TCGA-D8-A13Z-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicine | SD | |
FAM96B | insertion | Frame_Shift_Ins | novel | c.167_168insATTAGCAGAGAGGAAACTG | p.Glu57LeufsTer26 | p.E57Lfs*26 | Q9Y3D0 | protein_coding | TCGA-AN-A0FX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | ||
FAM96B | SNV | Missense_Mutation | c.484N>T | p.Arg162Cys | p.R162C | Q9Y3D0 | protein_coding | tolerated_low_confidence(0.1) | benign(0.01) | TCGA-EK-A2RN-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
FAM96B | SNV | Missense_Mutation | novel | c.171N>T | p.Glu57Asp | p.E57D | Q9Y3D0 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-A010-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Chemotherapy | folinic | CR |
FAM96B | SNV | Missense_Mutation | novel | c.70N>T | p.Gly24Trp | p.G24W | Q9Y3D0 | protein_coding | deleterious(0.01) | possibly_damaging(0.765) | TCGA-44-7661-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
FAM96B | SNV | Missense_Mutation | novel | c.157N>T | p.Ile53Phe | p.I53F | Q9Y3D0 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-MP-A4T9-01 | Lung | lung adenocarcinoma | Female | <65 | III/IV | Chemotherapy | vinorelbine | PD |
FAM96B | SNV | Missense_Mutation | c.144N>A | p.Asp48Glu | p.D48E | Q9Y3D0 | protein_coding | tolerated(0.22) | possibly_damaging(0.498) | TCGA-J4-A67Q-01 | Prostate | prostate adenocarcinoma | Male | >=65 | 6 | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |